Management of hepatocellular carcinoma on the waiting list before liver transplantation: time for controlled trials?
Majno
Pietro
P
Geneva Liver Cancer Study Group, University Hospitals of Geneva, Geneva, Switzerland. pietro.majno@hcuge.ch
Giostra
Emiliano
E
Mentha
Gilles
G
D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D017115:Catheter Ablation; D016461:Chemoembolization, Therapeutic / Q000379:methods; D002986:Clinical Trials as Topic; D018450:Disease Progression; D006801:Humans; D008099:Liver / Q000601:surgery; D008113:Liver Neoplasms / Q000628:therapy*; D016031:Liver Transplantation / Q000379:methods*; D008495:Medical Oncology / Q000379:methods; D013997:Time Factors; D009927:Tissue and Organ Procurement / Q000379:methods; D016896:Treatment Outcome; D014850:Waiting Lists